Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Employment test 11 - 50 employees
Company dna gill jennings and every llp
operating since 1912
Headquarter in London and 3 offices
active in Legal Services and IP Portfolio Processing

We have observed 6 EP applications Sarah Elizabeth Klaczynska has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11736498

DELIVERY OF RNA TO DIFFERENT CELL TYPES

IPC classification:
C12N 15/11, C12N 15/113
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Sarah Elizabeth Klaczynska, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12778013

RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES

IPC classification:
A61K 39/245, A61K 39/25, C12N 15/86
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12735420

IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/00, A61K 39/12, A61K 39/295, C07K 14/015, C07K 14/045
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP15738900

MENINGOCOCCUS VACCINES

IPC classification:
A61K 39/00, A61K 39/095, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Sarah Elizabeth Klaczynska, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15738352

MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES

IPC classification:
A61K 39/095, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Sarah Elizabeth Klaczynska, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP17177123

DELIVERY OF RNA TO TRIGGER MULTIPLE IMMUNE PATHWAYS

IPC classification:
A61K 39/00, A61K 39/12
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Sarah Elizabeth Klaczynska, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature